Healthcare
Wednesday, July 13, 2016
UPDATE 1-Citron's Left to go short on Valeant again - TheStreet
July 13 (Reuters) - Andrew Left, who runs short-selling firm
Citron Research, is planning to take a short position in Valeant
Pharmaceuticals International Inc again, TheStreet
reported.
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment